Recent FDA and HHS restructurings have created a new era of uncertainty for pharmaceutical marketers. With an understaffed OPDP, lengthened review timelines and evolving DTC advertising standards, the margin for error is shrinking fast. This article explores how these regulatory shifts are reshaping pharma marketing and why partnering with a specialized agency experienced in compliance and communication can make all the difference. Learn how seasoned partners help brands anticipate risk, maintain creative agility and keep launches on schedule without compromising accuracy or impact.

View article